Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin

This article provides billing and coding guidance that supplements LCD L39398 and CMS NCD 110.23 and describes additional locally covered indications for allogeneic hematopoietic cell transplantation in primary refractory or relapsed Hodgkin and non-Hodgkin lymphoma of B- or T-cell origin. Specific clinical eligibility criteria, exclusions, and frequency limits are not detailed here and require review of the referenced LCD and NCD for authoritative coverage rules.

"Allogeneic hematopoietic cell transplantation (HCT) may be locally covered for primary refractory or relapsed Hodgkin lymphoma and non-Hodgkin lymphoma of B-cell or T-cell origin as specified by th..."

Sign up to see full coverage criteria, indications, and limitations.